Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Public ClinicalTrials.gov record NCT01122784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomized, Single-Blinded Study to Evaluate the Safety and Immunogenicity of 80 µg Recombinant Plague Vaccine (rF1V) With and Without Adjuvant at Two Vaccination Schedules in Healthy Adult Volunteers
Study identification
- NCT ID
- NCT01122784
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Industry
- Enrollment
- 402 participants
Conditions and interventions
Conditions
Interventions
- rF1V vaccine (with Adjuvant) Biological
- rF1V vaccine (without Adjuvant) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Apr 30, 2012
- Completion
- Jun 30, 2012
- Last update posted
- Jul 29, 2020
2010 – 2012
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Benchmark Research | San Francisco | California | 94102 | — |
| Apex Research Institute | Santa Ana | California | 92705 | — |
| Johnson County Clinical Trials | Lenexa | Kansas | 66219 | — |
| Heartland Reseach Assoicates, LLC | Wichita | Kansas | 67207 | — |
| Central Kentucky Research Associates | Lexington | Kentucky | 40509 | — |
| WRAIR Clinical Trials Center | Silver Spring | Maryland | 20910 | — |
| Center for Pharmceutical Research | Kansas City | Missouri | 64114 | — |
| Rochester Clinical Research | Rochester | New York | 14609 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| New Orleans Center for Clinical Research | Knoxville | Tennessee | 70119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01122784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01122784 live on ClinicalTrials.gov.